Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.1 USD | +0.99% | -4.87% | -18.16% |
05-16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
05-15 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.16% | 169M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+36.44% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+27.49% | 12.08B | |
+22.40% | 11.94B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Transcript : Abeona Therapeutics Inc., Q3 2021 Earnings Call, Nov 17, 2021